Insulin-like growth factor-II: a novel autocrine growth factor modulating the apoptosis and maturation of umbilical cord blood erythroid progenitors

Experimental Hematology

Volumn 36, Issue 4, 2008, Pages 401-411

  Nagatomo, Taro ^a   Muta, Koichiro ^a   Ohga, Shouichi ^a   Ochiai, Masayuki ^a   Ohshima, Koichi ^b   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD36 ANTIGEN; ERYTHROPOIETIN; INTERLEUKIN 3; MESSENGER RNA; SOMATOMEDIN B; STEM CELL FACTOR;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

ANTIBODIES; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROID PROGENITOR CELLS; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LYMPHOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOMEDIN; RNA, MESSENGER;

EID: 40649103612     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.12.009     Document Type: Article

References (46)

1. McCarthy J.M., Capullari T., Thompson Z., Zhu Y., and Spellacy W.N. Umbilical cord nucleated red blood cell counts: normal values and the effect of labor. J Perinatol 26 (2006) 89
2. Majka M., Janowska-Wieczorek A., Ratajczak J., et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97 (2001) 3075-3085
3. McGrath K.E., and Palis J. Hematopoiesis in the yolk sac: more than meets the eye. Exp Hematol 33 (2005) 1021-1028
4. Baumann R., and Dragon S. Erythropoiesis and red cell function in vertebrate embryos. Eur J Clin Invest 35 Suppl 3 (2005) 2-12
5. Wojchowski D.M., Menon M.P., Sathyanarayana P., et al. Erythropoietin-dependent erythropoiesis: new insights and questions. Blood Cells Mol Dis 36 (2006) 232-238
6. Stopka T., Zivny J.H., Stopkova P., Prchal J.F., and Prchal J.T. Human hematopoietic progenitors express erythropoietin. Blood 91 (1998) 3766-3772
7. Frago L.M., and Chowen J.A. Basic physiology of the growth hormone/insulin-like growth factor axis. Adv Exp Med Biol 567 (2005) 1-25
8. Congote L.F., Mazza L., and Palfree R.G. Nucleotide sequence of the central coding region of bovine erythrotropin/insulin-like growth factor II cDNA from fetal intestine and northern analysis of the major IGF II transcripts at the time of hepatic erythropoiesis. Comp Biochem Physiol B 103 (1992) 127-131
9. Lund P.K., Moats-Staats B.M., Hynes M.A., et al. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261 (1986) 14539-14544
10. Constancia M., Hemberger M., Hughes J., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417 (2002) 945-948
11. O'Dell S.D., and Day I.N. Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30 (1998) 767-771
12. Muta K., Krantz S.B., Bondurant M.C., and Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94 (1994) 34-43
13. Dainiak N., and Kreczko S. Interactions of insulin, insulin-like growth factor II, and platelet-derived growth factor in erythropoietic culture. J Clin Invest 76 (1985) 1237-1242
14. Dainiak N., Sanders M., and Sorba S. Induction of circulating neonatal stem cell populations. Blood Cells 17 (1991) 339-343
15. Sanders M., Sorba S., and Dainiak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol 21 (1993) 25-30
16. Li Q., and Congote L.F. Bovine fetal-liver stromal cells support erythroid colony formation: enhancement by insulin-like growth factor II. Exp Hematol 23 (1995) 66-73
17. Edelman P., Vinci G., Villeval J.L., et al. A monoclonal antibody against an erythrocyte ontogenic antigen identifies fetal and adult erythroid progenitors. Blood 67 (1986) 56-63
18. Nagatomo T., Ohga S., Takada H., et al. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period. Clin Exp Immunol 138 (2004) 47-53
19. Tanaka T., Takada H., Nomura A., Ohga S., Shibata R., and Hara T. Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol 140 (2005) 524-531
20. Sawada K., Krantz S.B., Dessypris E.N., Koury S.T., and Sawyer S.T. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 83 (1989) 1701-1709
21. Choi I., Muta K., Wickrema A., Krantz S.B., Nishimura J., and Nawata H. Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. Blood 95 (2000) 3742-3749
22. Matsushima T., Nakashima M., Oshima K., et al. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 98 (2001) 313-321
23. Stewart C.E., and Rotwein P. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271 (1996) 11330-11338
24. Gabbitas B., Pash J., and Canalis E. Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology 135 (1994) 284-289
25. Logie A., Boulle N., Gaston V., et al. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. J Mol Endocrinol 23 (1999) 23-32
26. E El-Badry O.M., Helman L.J., Chatten J., Steinberg S.M., Evans A.E., and Israel M.A. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87 (1991) 648-657
27. Morison I.M., Eccles M.R., and Reeve A.E. Imprinting of insulin-like growth factor 2 is modulated during hematopoiesis. Blood 96 (2000) 3023-3028
28. Giannoukakis N., Deal C., Paquette J., Kukuvitis A., and Polychronakos C. Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun 220 (1996) 1014-1019
29. Kim K.W., Bae S.K., Lee O.H., Bae M.H., Lee M.J., and Park B.C. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58 (1998) 348-351
30. Fukuoka H., Aoyama M., Miyazawa K., Asai K., and Goto S. Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells. Biochem Biophys Res Commun 328 (2005) 885-894
31. Tapanainen P.J., Bang P., Wilson K., Unterman T.G., Vreman H.J., and Rosenfeld R.G. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res 36 (1994) 152-158
32. McCarthy J.M., Capullari T., Thompson Z., Zhu Y., and Spellacy W.N. Umbilical cord nucleated red blood cell counts: normal values and the effect of labor. J Perinatol 26 (2006) 89-92
33. Schwartz G.N., Warren M.K., Sakano K., et al. Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis. Stem Cells 14 (1996) 337-350
34. Merchav S., Silvian-Drachsler I., Tatarsky I., Lake M., and Skottner A. Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II. J Clin Endocrinol Metab 74 (1992) 447-452
35. Ludwig T., Eggenschwiler J., Fisher P., D'Ercole A.J., Davenport M.L., and Efstratiadis A. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177 (1996) 517-535
36. Lau M.M., Stewart C.E., Liu Z., Bhatt H., Rotwein P., and Stewart C.L. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8 (1994) 2953-2963
37. Tachikawa Y., Matsushima T., Abe Y., et al. Pivotal role of Notch signaling in regulation of erythroid maturation and proliferation. Eur J Haematol 77 (2006) 273-281
38. Liu E., Law H.K., and Lau Y.L. Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways. Pediatr Res 54 (2003) 919-925
39. Welniak L.A., Karas M., Yakar S., Anver M.R., Murphy W.J., and LeRoith D. Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis. Biol Blood Marrow Transplant 10 (2004) 32-39
40. Miharada K., Hiroyama T., Sudo K., Nagasawa T., and Nakamura Y. Refinement of cytokine use in the in vitro expansion of erythroid cells. Hum Cell 19 (2006) 30-37
41. Zhang C.C., and Lodish H.F. Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 103 (2004) 2513-2521
42. Sennikov S.V., Injelevskaya T.V., Krysov S.V., et al. Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow. BMC Cell Biol 5 (2004) 39
43. Shimon I., and Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res 19 (1995) 233-240
44. Lee O.H., Bae S.K., Bae M.H., et al. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 82 (2000) 385-391
45. Palka J.A., Karna E., and Miltyk W. Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol Cell Biochem 168 (1997) 177-183
46. Grotendorst G.R., Rahmanie H., and Duncan M.R. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18 (2004) 469-479